• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子对接模拟的 SARS-CoV-2 潜在抑制剂的天然产物计算机筛选。

In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.

机构信息

Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, 8100, Bangladesh.

Harmacy Discipline, Life Science School, Khulna University, Khulna, 9280, Bangladesh.

出版信息

Chin J Integr Med. 2022 Mar;28(3):249-256. doi: 10.1007/s11655-021-3504-5. Epub 2021 Dec 15.

DOI:10.1007/s11655-021-3504-5
PMID:34913151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8672856/
Abstract

OBJECTIVE

To explore potential natural products against severe acute respiratory syndrome coronavirus (SARS-CoV-2) via the study of structural and non-structural proteins of human coronaviruses.

METHODS

In this study, we performed an in-silico survey of 25 potential natural compounds acting against SARS-CoV-2. Molecular docking studies were carried out using compounds against 3-chymotrypsin-like protease (3CL), papain-like protease (PL), RNA-dependent RNA polymerase (RdRp), non-structural protein (nsp), human angiotensin converting enzyme 2 receptor (hACE2R), spike glycoprotein (S protein), abelson murine leukemia viral oncogene homolog 1 (ABL1), calcineurin-nuclear factor of activated T-cells (NFAT) and transmembrane protease serine 2.

RESULTS

Among the screened compounds, amentoflavone showed the best binding affinity with the 3CL, RdRp, nsp13, nsp15, hACE2R. ABL1 and calcineurin-NFAT; berbamine with hACE2R and ABL1; cepharanthine with nsp10, nsp14, nsp16, S protein and ABL1; glucogallin with nsp15; and papyriflavonol A with PL protein. Other good interacting compounds were juglanin, betulinic acid, betulonic acid, broussooflavan A, tomentin A, B and E, 7-methoxycryptopleurine, aloe emodin, quercetin, tanshinone I, tylophorine and furruginol, which also showed excellent binding affinity towards a number of target proteins. Most of these compounds showed better binding affinities towards the target proteins than the standard drugs used in this study.

CONCLUSION

Natural products or their derivatives may be one of the potential targets to fight against SARS-CoV-2.

摘要

目的

通过研究人类冠状病毒的结构和非结构蛋白,探索潜在的抗严重急性呼吸综合征冠状病毒(SARS-CoV-2)的天然产物。

方法

在本研究中,我们针对 25 种可能对抗 SARS-CoV-2 的天然化合物进行了计算机筛选。使用针对 3-糜蛋白酶样蛋白酶(3CL)、木瓜蛋白酶样蛋白酶(PL)、RNA 依赖性 RNA 聚合酶(RdRp)、非结构蛋白(nsp)、人血管紧张素转换酶 2 受体(hACE2R)、刺突糖蛋白(S 蛋白)、abl 原癌基因同源物 1(ABL1)、钙调神经磷酸酶-活化 T 细胞核因子(NFAT)和跨膜丝氨酸蛋白酶 2 的化合物进行了分子对接研究。

结果

在所筛选的化合物中,穗花杉双黄酮与 3CL、RdRp、nsp13、nsp15、hACE2R、ABL1 和钙调神经磷酸酶-NFAT 具有最佳的结合亲和力;小檗胺与 hACE2R 和 ABL1 具有最佳的结合亲和力;蛇菰宁与 nsp10、nsp14、nsp16、S 蛋白和 ABL1 具有最佳的结合亲和力;芦丁与 nsp15 具有最佳的结合亲和力;以及黄瑞香素 A 与 PL 蛋白具有最佳的结合亲和力。其他具有良好相互作用的化合物还有 Juglanin、桦木酸、羽扇豆酸、黄瑞香素 A、B 和 E、7-甲氧基隐丹参酮、芦荟大黄素、槲皮素、丹参酮 I、盐酸千里光碱和 furruginol,它们也与许多靶蛋白表现出良好的结合亲和力。这些化合物中的大多数对靶蛋白的结合亲和力优于本研究中使用的标准药物。

结论

天然产物或其衍生物可能是对抗 SARS-CoV-2 的潜在靶点之一。

相似文献

1
In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.基于分子对接模拟的 SARS-CoV-2 潜在抑制剂的天然产物计算机筛选。
Chin J Integr Med. 2022 Mar;28(3):249-256. doi: 10.1007/s11655-021-3504-5. Epub 2021 Dec 15.
2
Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.具有串联抗炎、免疫调节和抗SARS-CoV/2作用的天然产物:针对SARS-CoV-2的药物发现视角
Curr Med Chem. 2022;29(14):2530-2564. doi: 10.2174/0929867328666210726094955.
3
Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an Approach.采用一种方法发现一些对抗新型冠状病毒(SARS-CoV-2)的抗病毒天然产物。
Comb Chem High Throughput Screen. 2021;24(8):1271-1280. doi: 10.2174/1386207323666200902135928.
4
Amentoflavone derivatives significantly act towards the main protease (3CL/M) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology.阿魏酸衍生物对 SARS-CoV-2 的主要蛋白酶(3CL/M)有显著作用:计算机辅助 ADMET 分析、分子对接、分子动力学模拟、网络药理学。
Mol Divers. 2023 Apr;27(2):857-871. doi: 10.1007/s11030-022-10459-9. Epub 2022 May 31.
5
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.利用天然化合物靶向 SARS-CoV-2 感染的药物发现的当前方法。
Virus Res. 2020 Dec;290:198169. doi: 10.1016/j.virusres.2020.198169. Epub 2020 Sep 24.
6
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL and PL), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2).类黄酮作为针对 SARS-CoV-2 蛋白酶(3CL 和 PL)、刺突蛋白、RNA 依赖性 RNA 聚合酶(RdRp)和血管紧张素转换酶 II 受体(ACE2)的潜在抗病毒药物。
Eur J Pharmacol. 2021 Jan 15;891:173759. doi: 10.1016/j.ejphar.2020.173759. Epub 2020 Nov 27.
7
Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.基于分子模拟的高活性天然产物研究以阻断 SARS-CoV-2 的 nsp10-nsp16 复合物的形成。
Biomolecules. 2021 Apr 14;11(4):573. doi: 10.3390/biom11040573.
8
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL and 3CL proteases.虚拟高通量筛选:SARS-CoV-2 PL 和 3CL 蛋白酶的潜在抑制剂。
Eur J Pharmacol. 2021 Jun 15;901:174082. doi: 10.1016/j.ejphar.2021.174082. Epub 2021 Apr 3.
9
Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.天然化合物对 SARS 刺突糖蛋白-人血管紧张素转换酶 2 和 SARS-CoV-2 主蛋白酶的分子对接和 ADMET 预测。
Arch Razi Inst. 2021 Sep 1;76(3):453-459. doi: 10.22092/ari.2020.351202.1517. eCollection 2021 Summer.
10
Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.依米丁,一种针对 SARS-CoV-2 木瓜蛋白酶样蛋白酶和非结构蛋白的有效生物碱:药代动力学、分子对接和动态研究。
J Biomol Struct Dyn. 2022;40(20):10122-10135. doi: 10.1080/07391102.2021.1946715. Epub 2021 Jul 13.

引用本文的文献

1
Exploring acupuncture as a therapeutic approach for tic disorders: a review of current understanding and potential benefits.探索针灸作为抽动障碍的一种治疗方法:对当前认识和潜在益处的综述
Front Neurol. 2025 Mar 14;16:1447818. doi: 10.3389/fneur.2025.1447818. eCollection 2025.
2
Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial : Author detials.口服千金藤素在非住院、无症状或轻症新冠患者中的安全性和有效性:一项双盲、随机、安慰剂对照试验:作者详情
Sci Rep. 2025 Jan 31;15(1):3875. doi: 10.1038/s41598-024-75891-3.
3
Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment.调节p53-MDM2信号通路:天然化合物在癌症治疗中的治疗潜力。
EXCLI J. 2024 Nov 22;23:1397-1439. doi: 10.17179/excli2024-7791. eCollection 2024.
4
Synergistic Inhibition of Breast Carcinoma Cell Proliferation by Quercetin and Sulforaphane via Activation of the ERK/MAPK Pathway.槲皮素和萝卜硫素通过激活ERK/MAPK途径协同抑制乳腺癌细胞增殖
Cell Biochem Biophys. 2025 Jun;83(2):2533-2546. doi: 10.1007/s12013-024-01662-6. Epub 2025 Jan 6.
5
Natural products as drug leads: exploring their potential in drug discovery and development.天然产物作为药物先导物:探索其在药物发现与开发中的潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4673-4687. doi: 10.1007/s00210-024-03622-6. Epub 2024 Dec 2.
6
A Comprehensive Review of Molecular Mechanisms, Pharmacokinetics, Toxicology and Plant Sources of Juglanin: Current Landscape and Future Perspectives.关于黄杞苷的分子机制、药代动力学、毒理学和植物来源的全面综述:现状与展望。
Int J Mol Sci. 2024 Sep 25;25(19):10323. doi: 10.3390/ijms251910323.
7
A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data.一种用于整合局部-全局特征的深度学习药物筛选框架:针对有限数据的新尝试。
Heliyon. 2024 Jul 14;10(14):e34244. doi: 10.1016/j.heliyon.2024.e34244. eCollection 2024 Jul 30.
8
Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection.针对 SARS-CoV-2 感染的一些市售抗病毒药物及其衍生物的分子建模。
Narra J. 2024 Apr;4(1):e319. doi: 10.52225/narra.v4i1.319. Epub 2024 Apr 30.
9
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.槲皮素及其衍生物在新冠病毒防护和预防方面的治疗意义。
Heliyon. 2024 Apr 30;10(9):e30080. doi: 10.1016/j.heliyon.2024.e30080. eCollection 2024 May 15.
10
Assessment of Quercetin Antiemetic Properties: In Vivo and In Silico Investigations on Receptor Binding Affinity and Synergistic Effects.槲皮素止吐特性的评估:关于受体结合亲和力和协同效应的体内及计算机模拟研究
Plants (Basel). 2023 Dec 18;12(24):4189. doi: 10.3390/plants12244189.

本文引用的文献

1
analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2.分析血管紧张素转换酶2(ACE2)直系同源物以预测对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)高度易感的动物宿主范围。
3 Biotech. 2020 Nov;10(11):483. doi: 10.1007/s13205-020-02471-3. Epub 2020 Oct 21.
2
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对动物血管紧张素转换酶2受体的广泛及差异性利用
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00940-20.
3
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.TMPRSS2 和 TMPRSS4 促进 SARS-CoV-2 感染人小肠肠细胞。
Sci Immunol. 2020 May 13;5(47). doi: 10.1126/sciimmunol.abc3582.
4
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).迈向有效的 COVID-19 疫苗:更新、观点和挑战(综述)。
Int J Mol Med. 2020 Jul;46(1):3-16. doi: 10.3892/ijmm.2020.4596. Epub 2020 May 6.
5
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
6
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.天然产物及其衍生物抗冠状病毒:非临床和临床前数据的综述。
Phytother Res. 2020 Oct;34(10):2471-2492. doi: 10.1002/ptr.6700. Epub 2020 Apr 17.
7
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.利巴韦林、瑞德西韦、索非布韦、加洛韦和替诺福韦对 SARS-CoV-2 RNA 依赖的 RNA 聚合酶(RdRp)的抑制作用:一项分子对接研究。
Life Sci. 2020 Jul 15;253:117592. doi: 10.1016/j.lfs.2020.117592. Epub 2020 Mar 25.
8
Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An analysis.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白变化在与人类血管紧张素转换酶2(ACE2)受体相互作用中的作用:一项分析
EXCLI J. 2020 Mar 18;19:410-417. doi: 10.17179/excli2020-1167. eCollection 2020.
9
Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.计算机与病毒性疾病。针对 SARS-CoV-2(2019-nCoV,COVID-19)冠状病毒的合成疫苗和预防性肽模拟拮抗剂的设计的初步生物信息学研究。
Comput Biol Med. 2020 Apr;119:103670. doi: 10.1016/j.compbiomed.2020.103670. Epub 2020 Feb 26.
10
High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.高通量筛选和鉴定冠状病毒广谱强效抑制剂。
J Virol. 2019 May 29;93(12). doi: 10.1128/JVI.00023-19. Print 2019 Jun 15.